Piramal Pharma has announced the availability of the transcript from its conference call held on November 6th, 2025, regarding the unaudited financial results (standalone and consolidated) for the quarter and half-year ended September 30th, 2025. The transcript is accessible on the company’s website, providing detailed insights into the company’s performance and future outlook. This information is crucial for investors seeking in-depth analysis of Piramal Pharma’s financial standing.
Conference Call Transcript Available
Piramal Pharma has released the transcript of its conference call pertaining to the unaudited financial results for the quarter and half-year ended September 30th, 2025. The call took place on November 6th, 2025.
Financial Results Discussion
The transcript provides a detailed record of the discussions and insights shared during the conference call. It covers the company’s performance on both a standalone and consolidated basis.
Accessing the Transcript
Interested parties can access the full transcript on the Piramal Pharma website. This resource provides an in-depth understanding of the company’s financial performance for Q2 FY26 and H1 FY26.
Source: BSE
